DNA mismatch repair as an effector for promoting phorbol ester-induced apoptotic DNA damage and cell killing

Implications in tumor promotion

Ching Tai Lin, Wei Hsin Lin, Kuan Der Lee, Pay Yu Tzeng

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Phorbol ester was known to activate protein kinase C (PKC) and exert numerous cellular effects, including proliferation, apoptosis, and oncogenic transformation. How phorbol ester stimulates both apoptosis and tumor promotion is not clear. Here DNA mismatch repair (MMR)-proficient human colon cancer cells (DLD-1+Ch2; hMSH6+) treated with l2-O-tetradecanoylphorbol-13- acetate (TPA) undergo rapid cell death, which is significantly abolished by staurosporine (PKC inhibitor) or antioxidant, compared with the paired MMR-deficient (DLD-1; hMSH6-) cells. Induction of reactive oxygen species (ROS) by TPA is shown to be one of downstream effectors required, but not sufficient, for cell killing as it is also observed in DLD-1 cells. Strikingly, DLD-1+Ch2 cells selected for resistance to TPA are found to lose the expression of hMSH6. Treatment of TPA-resistant DLD4+Ch2 cells with 5-aza-2′-deoxycytidine, not only restores hMSH6 expression but also resensitizes TPA-resistant cells to TPA, suggesting that expression of hMSH6 is transcriptionally silenced by cytosine methylation confirmed directly by bisulfite sequencing. Knockdown hMSH6 or hPMS2 with siRNA in DLD-1+Ch2 cells resulted in more resistant to TPA-induced cell killing, further suggesting that MMR proteins involve in TPA or ROS-induced cell killing. Results suggest that deficiency in MMR could promote tumorigenesis by inhibiting apoptotic responses to ROS-mediated DNA damages as ROS are continuously produced as a byproduct of normal metabolism.

Original languageEnglish
Pages (from-to)1776-1784
Number of pages9
JournalInternational Journal of Cancer
Volume119
Issue number8
DOIs
Publication statusPublished - Oct 15 2006
Externally publishedYes

Fingerprint

DNA Mismatch Repair
Phorbol Esters
DNA Damage
Tetradecanoylphorbol Acetate
Neoplasms
Reactive Oxygen Species
decitabine
Protein Kinase C
Apoptosis
Staurosporine
Protein C Inhibitor
Cytosine
Protein Kinase Inhibitors
Colonic Neoplasms
Methylation
Small Interfering RNA
Carcinogenesis
Cell Death
Antioxidants

Keywords

  • DNA methylation
  • DNA mismatch repair
  • Drug resistance
  • Gene silencing
  • Phorbol ester

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

DNA mismatch repair as an effector for promoting phorbol ester-induced apoptotic DNA damage and cell killing : Implications in tumor promotion. / Lin, Ching Tai; Lin, Wei Hsin; Lee, Kuan Der; Tzeng, Pay Yu.

In: International Journal of Cancer, Vol. 119, No. 8, 15.10.2006, p. 1776-1784.

Research output: Contribution to journalArticle

@article{bfe0d2268969415785d3f90729c52cda,
title = "DNA mismatch repair as an effector for promoting phorbol ester-induced apoptotic DNA damage and cell killing: Implications in tumor promotion",
abstract = "Phorbol ester was known to activate protein kinase C (PKC) and exert numerous cellular effects, including proliferation, apoptosis, and oncogenic transformation. How phorbol ester stimulates both apoptosis and tumor promotion is not clear. Here DNA mismatch repair (MMR)-proficient human colon cancer cells (DLD-1+Ch2; hMSH6+) treated with l2-O-tetradecanoylphorbol-13- acetate (TPA) undergo rapid cell death, which is significantly abolished by staurosporine (PKC inhibitor) or antioxidant, compared with the paired MMR-deficient (DLD-1; hMSH6-) cells. Induction of reactive oxygen species (ROS) by TPA is shown to be one of downstream effectors required, but not sufficient, for cell killing as it is also observed in DLD-1 cells. Strikingly, DLD-1+Ch2 cells selected for resistance to TPA are found to lose the expression of hMSH6. Treatment of TPA-resistant DLD4+Ch2 cells with 5-aza-2′-deoxycytidine, not only restores hMSH6 expression but also resensitizes TPA-resistant cells to TPA, suggesting that expression of hMSH6 is transcriptionally silenced by cytosine methylation confirmed directly by bisulfite sequencing. Knockdown hMSH6 or hPMS2 with siRNA in DLD-1+Ch2 cells resulted in more resistant to TPA-induced cell killing, further suggesting that MMR proteins involve in TPA or ROS-induced cell killing. Results suggest that deficiency in MMR could promote tumorigenesis by inhibiting apoptotic responses to ROS-mediated DNA damages as ROS are continuously produced as a byproduct of normal metabolism.",
keywords = "DNA methylation, DNA mismatch repair, Drug resistance, Gene silencing, Phorbol ester",
author = "Lin, {Ching Tai} and Lin, {Wei Hsin} and Lee, {Kuan Der} and Tzeng, {Pay Yu}",
year = "2006",
month = "10",
day = "15",
doi = "10.1002/ijc.22068",
language = "English",
volume = "119",
pages = "1776--1784",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - DNA mismatch repair as an effector for promoting phorbol ester-induced apoptotic DNA damage and cell killing

T2 - Implications in tumor promotion

AU - Lin, Ching Tai

AU - Lin, Wei Hsin

AU - Lee, Kuan Der

AU - Tzeng, Pay Yu

PY - 2006/10/15

Y1 - 2006/10/15

N2 - Phorbol ester was known to activate protein kinase C (PKC) and exert numerous cellular effects, including proliferation, apoptosis, and oncogenic transformation. How phorbol ester stimulates both apoptosis and tumor promotion is not clear. Here DNA mismatch repair (MMR)-proficient human colon cancer cells (DLD-1+Ch2; hMSH6+) treated with l2-O-tetradecanoylphorbol-13- acetate (TPA) undergo rapid cell death, which is significantly abolished by staurosporine (PKC inhibitor) or antioxidant, compared with the paired MMR-deficient (DLD-1; hMSH6-) cells. Induction of reactive oxygen species (ROS) by TPA is shown to be one of downstream effectors required, but not sufficient, for cell killing as it is also observed in DLD-1 cells. Strikingly, DLD-1+Ch2 cells selected for resistance to TPA are found to lose the expression of hMSH6. Treatment of TPA-resistant DLD4+Ch2 cells with 5-aza-2′-deoxycytidine, not only restores hMSH6 expression but also resensitizes TPA-resistant cells to TPA, suggesting that expression of hMSH6 is transcriptionally silenced by cytosine methylation confirmed directly by bisulfite sequencing. Knockdown hMSH6 or hPMS2 with siRNA in DLD-1+Ch2 cells resulted in more resistant to TPA-induced cell killing, further suggesting that MMR proteins involve in TPA or ROS-induced cell killing. Results suggest that deficiency in MMR could promote tumorigenesis by inhibiting apoptotic responses to ROS-mediated DNA damages as ROS are continuously produced as a byproduct of normal metabolism.

AB - Phorbol ester was known to activate protein kinase C (PKC) and exert numerous cellular effects, including proliferation, apoptosis, and oncogenic transformation. How phorbol ester stimulates both apoptosis and tumor promotion is not clear. Here DNA mismatch repair (MMR)-proficient human colon cancer cells (DLD-1+Ch2; hMSH6+) treated with l2-O-tetradecanoylphorbol-13- acetate (TPA) undergo rapid cell death, which is significantly abolished by staurosporine (PKC inhibitor) or antioxidant, compared with the paired MMR-deficient (DLD-1; hMSH6-) cells. Induction of reactive oxygen species (ROS) by TPA is shown to be one of downstream effectors required, but not sufficient, for cell killing as it is also observed in DLD-1 cells. Strikingly, DLD-1+Ch2 cells selected for resistance to TPA are found to lose the expression of hMSH6. Treatment of TPA-resistant DLD4+Ch2 cells with 5-aza-2′-deoxycytidine, not only restores hMSH6 expression but also resensitizes TPA-resistant cells to TPA, suggesting that expression of hMSH6 is transcriptionally silenced by cytosine methylation confirmed directly by bisulfite sequencing. Knockdown hMSH6 or hPMS2 with siRNA in DLD-1+Ch2 cells resulted in more resistant to TPA-induced cell killing, further suggesting that MMR proteins involve in TPA or ROS-induced cell killing. Results suggest that deficiency in MMR could promote tumorigenesis by inhibiting apoptotic responses to ROS-mediated DNA damages as ROS are continuously produced as a byproduct of normal metabolism.

KW - DNA methylation

KW - DNA mismatch repair

KW - Drug resistance

KW - Gene silencing

KW - Phorbol ester

UR - http://www.scopus.com/inward/record.url?scp=33748508401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748508401&partnerID=8YFLogxK

U2 - 10.1002/ijc.22068

DO - 10.1002/ijc.22068

M3 - Article

VL - 119

SP - 1776

EP - 1784

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 8

ER -